Published in J Struct Biol on August 06, 2011
Pre-existent asymmetry in the human cyclooxygenase-2 sequence homodimer. J Biol Chem (2013) 0.92
The structure of ibuprofen bound to cyclooxygenase-2. J Struct Biol (2014) 0.85
Cyclooxygenase-2 catalysis and inhibition in lipid bilayer nanodiscs. Arch Biochem Biophys (2014) 0.81
Regulation of rat intrapulmonary arterial tone by arachidonic acid and prostaglandin E2 during hypoxia. PLoS One (2013) 0.76
Substrate-selective Inhibition of Cyclooxygeanse-2 by Fenamic Acid Derivatives Is Dependent on Peroxide Tone. J Biol Chem (2016) 0.76
Ginger components as new leads for the design and development of novel multi-targeted anti-Alzheimer's drugs: a computational investigation. Drug Des Devel Ther (2014) 0.76
Crystal structure of rofecoxib bound to human cyclooxygenase-2. Acta Crystallogr F Struct Biol Commun (2016) 0.75
The COX-2-Selective Antagonist (NS-398) Inhibits Choroidal Neovascularization and Subretinal Fibrosis. PLoS One (2016) 0.75
Fatty Acid Binding to the Allosteric Subunit of Cyclooxygenase-2 Relieves a Tonic Inhibition of the Catalytic Subunit. J Biol Chem (2016) 0.75
A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information. Nat Commun (2017) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr (1997) 137.43
Phaser crystallographic software. J Appl Crystallogr (2007) 108.34
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res (2007) 37.31
Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7. Nat Protoc (2008) 16.53
Developments in the CCP4 molecular-graphics project. Acta Crystallogr D Biol Crystallogr (2004) 13.53
A graphical user interface to the CCP4 program suite. Acta Crystallogr D Biol Crystallogr (2003) 13.43
Main-chain bond lengths and bond angles in protein structures. J Mol Biol (1993) 9.80
Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem (2000) 8.86
The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature (1994) 5.94
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature (1997) 5.11
NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins (1994) 2.60
The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Nat Struct Biol (1995) 2.56
Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. J Biol Chem (2000) 2.48
Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2. J Biol Chem (1997) 2.18
Cyclooxygenases: structural and functional insights. J Lipid Res (2008) 2.14
Collaborative Computational Project, number 4: providing programs for protein crystallography. Methods Enzymol (1997) 2.11
Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J Biol Chem (2007) 2.10
Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediat (2002) 1.95
Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nat Struct Biol (1996) 1.92
Structural insights into the stereochemistry of the cyclooxygenase reaction. Nature (2000) 1.79
Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors. Proc Natl Acad Sci U S A (2000) 1.75
Structural and functional basis of cyclooxygenase inhibition. J Med Chem (2007) 1.75
The COXIB experience: a look in the rearview mirror. Annu Rev Pharmacol Toxicol (2009) 1.74
A novel mechanism of cyclooxygenase-2 inhibition involving interactions with Ser-530 and Tyr-385. J Biol Chem (2003) 1.69
A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors. J Biol Chem (1996) 1.61
Structural analysis of NSAID binding by prostaglandin H2 synthase: time-dependent and time-independent inhibitors elicit identical enzyme conformations. Biochemistry (2001) 1.58
NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen Pharmacol (1993) 1.52
Structural basis of fatty acid substrate binding to cyclooxygenase-2. J Biol Chem (2010) 1.33
The structures of prostaglandin endoperoxide H synthases-1 and -2. Prostaglandins Other Lipid Mediat (2002) 1.22
Molecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxen. J Biol Chem (2010) 1.22
Cox-2-selective inhibitors: the new super aspirins. Mol Pharmacol (1999) 1.17
Structural basis of enantioselective inhibition of cyclooxygenase-1 by S-alpha-substituted indomethacin ethanolamides. J Biol Chem (2007) 1.16
The structural basis of endocannabinoid oxygenation by cyclooxygenase-2. J Biol Chem (2011) 1.16
The role of arginine 120 of human prostaglandin endoperoxide H synthase-2 in the interaction with fatty acid substrates and inhibitors. J Biol Chem (1999) 1.15
Identification of two cyclooxygenase active site residues, Leucine 384 and Glycine 526, that control carbon ring cyclization in prostaglandin biosynthesis. J Biol Chem (2003) 1.13
Conversion of prostaglandin G/H synthase-1 into an enzyme sensitive to PGHS-2-selective inhibitors by a double His513 --> Arg and Ile523 --> val mutation. J Biol Chem (1997) 1.13
Role of Val509 in time-dependent inhibition of human prostaglandin H synthase-2 cyclooxygenase activity by isoform-selective agents. J Biol Chem (1996) 1.08
Comparison of cyclooxygenase-1 crystal structures: cross-talk between monomers comprising cyclooxygenase-1 homodimers. Biochemistry (2010) 0.94
The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs. Mol Pharmacol (1997) 0.90
The novel benzopyran class of selective cyclooxygenase-2 inhibitors-part I: the first clinical candidate. Bioorg Med Chem Lett (2010) 0.82
Structure of the integral membrane protein CAAX protease Ste24p. Science (2013) 1.38
Structural basis of fatty acid substrate binding to cyclooxygenase-2. J Biol Chem (2010) 1.33
Structural genomics: from genes to structures with valuable materials and many questions in between. Nat Methods (2008) 1.33
Human cyclooxygenase-2 is a sequence homodimer that functions as a conformational heterodimer. J Biol Chem (2011) 1.31
Pleiotropic mechanisms facilitated by resveratrol and its metabolites. Biochem J (2010) 1.26
The structures of prostaglandin endoperoxide H synthases-1 and -2. Prostaglandins Other Lipid Mediat (2002) 1.22
Efficient optimization of crystallization conditions by manipulation of drop volume ratio and temperature. Protein Sci (2007) 1.22
The structural basis of endocannabinoid oxygenation by cyclooxygenase-2. J Biol Chem (2011) 1.16
Establishing a training set through the visual analysis of crystallization trials. Part I: approximately 150,000 images. Acta Crystallogr D Biol Crystallogr (2008) 1.15
Establishing a training set through the visual analysis of crystallization trials. Part II: crystal examples. Acta Crystallogr D Biol Crystallogr (2008) 1.12
Purification of transmembrane proteins from Saccharomyces cerevisiae for X-ray crystallography. Protein Expr Purif (2010) 1.05
Coordinating the impact of structural genomics on the human α-helical transmembrane proteome. Nat Struct Mol Biol (2013) 1.05
Determination and application of empirically derived detergent phase boundaries to effectively crystallize membrane proteins. Protein Sci (2009) 1.02
Investigating substrate promiscuity in cyclooxygenase-2: the role of Arg-120 and residues lining the hydrophobic groove. J Biol Chem (2012) 0.97
His-311 and Arg-559 are key residues involved in fatty acid oxygenation in pathogen-inducible oxygenase. J Biol Chem (2008) 0.92
Role of the zinc uptake ABC transporter of Moraxella catarrhalis in persistence in the respiratory tract. Infect Immun (2013) 0.88
The transition from closed to open conformation of Treponema pallidum outer membrane-associated lipoprotein TP0453 involves membrane sensing and integration by two amphipathic helices. J Biol Chem (2011) 0.86
The crystal structure of α-Dioxygenase provides insight into diversity in the cyclooxygenase-peroxidase superfamily. Biochemistry (2013) 0.80
Crystal structures of α-dioxygenase from Oryza sativa: insights into substrate binding and activation by hydrogen peroxide. Protein Sci (2013) 0.77